C07C 215/06
And acyclic
Official title: and acyclic
C07C215/06 (And acyclic) appears on 671 US grants and 641 published applications in this corpus.
Search patents in C07C- Granted patents
- 671
- Published applications
- 641
- Assignees
- 447
- Inventors
- 1,857
- Latest grant
- 16 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 6 | 0 |
| 1977 | 2 | 0 |
| 1978 | 4 | 0 |
| 1979 | 3 | 0 |
| 1980 | 1 | 0 |
| 1981 | 2 | 0 |
| 1982 | 3 | 0 |
| 1983 | 3 | 0 |
| 1984 | 3 | 0 |
| 1985 | 1 | 0 |
| 1986 | 2 | 0 |
| 1987 | 3 | 0 |
| 1988 | 9 | 0 |
| 1989 | 10 | 0 |
| 1990 | 8 | 0 |
| 1991 | 9 | 0 |
| 1992 | 13 | 0 |
| 1993 | 12 | 0 |
| 1994 | 9 | 0 |
| 1995 | 10 | 0 |
| 1996 | 22 | 0 |
| 1997 | 32 | 0 |
| 1998 | 28 | 0 |
| 1999 | 14 | 0 |
| 2000 | 8 | 0 |
| 2001 | 8 | 4 |
| 2002 | 16 | 13 |
| 2003 | 13 | 34 |
| 2004 | 26 | 14 |
| 2005 | 10 | 18 |
| 2006 | 14 | 16 |
| 2007 | 4 | 16 |
| 2008 | 11 | 17 |
| 2009 | 14 | 23 |
| 2010 | 12 | 20 |
| 2011 | 12 | 26 |
| 2012 | 13 | 32 |
| 2013 | 22 | 28 |
| 2014 | 29 | 42 |
| 2015 | 26 | 37 |
| 2016 | 32 | 29 |
| 2017 | 19 | 30 |
| 2018 | 20 | 36 |
| 2019 | 26 | 29 |
| 2020 | 32 | 28 |
| 2021 | 23 | 33 |
| 2022 | 23 | 27 |
| 2023 | 17 | 28 |
| 2024 | 8 | 21 |
| 2025 | 15 | 23 |
| 2026 | 9 | 17 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C07C 215/08With only one hydroxy group and one amino group bound to the301
- C07C 215/10With one amino group and at least two hydroxy groups bound to170
- C07C 215/14The nitrogen atom of the amino group being further bound to hydrocarbon100
- C07C 215/18With hydroxy groups and at least two amino groups bound to the96
- C07C 215/12The nitrogen atom of the amino group being further bound to hydrocarbon74
- C07C 215/16The nitrogen atom of the amino group being further bound to carbon63
Recent patents
- Cannabinoid sulfate esters, their salts and uses thereof16 Jun 2026US 12,655,094 B2London Pharmaceuticals and Research Corporation
- Ionizable lipid compounds and lipid nanoparticle compositions16 Jun 2026US 12,655,114 B2SunVax mRNA Therapeutics Inc.
- Artificially synthesized sphingosine derivative lipoid monomer and use of same for delivering nucleic acid19 May 2026US 12,629,421 B2Beijing Baishihekang Pharmaceutical Technology (Bsjpharma) Co., Ltd
- Stereoselective process for preparing substituted polycyclic pyridone28 Apr 2026US 12,612,415 B2Shionogi & Co., Ltd.
- Non-cationic softeners and methods of use14 Apr 2026US 12,600,924 B2Ecolab USA Inc.
- Crystalline forms or salts of a deuterated compound13 Aug 2026US 2026/0234135 A1Alebund Pharmaceuticals (Hong Kong) Limited
- Artificially synthesized sphingosine derivative lipoid monomer and use of same for delivering nucleic acid6 Aug 2026US 2026/0224704 A1Beijing Baishihekang Pharmaceutical Technology (Bsjpharma) Co., Ltd
- Pharmaceutically acceptable salt and crystal form of triazole compound, and preparation method therefor6 Aug 2026US 2026/0226025 A1Jiangsu Hengrui Pharmaceuticals Co., Ltd.
- Salt and crystal form of cycloalkene compound, and preparation method therefor and use thereof6 Aug 2026US 2026/0226046 A1Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
- Surfactant compositions derived from waste streams, and methods30 Jul 2026US 2026/0218053 A1Kemira Oyj
Most cited
By later US patents
- Non-nucleoside linkers for convenient attachment of labels to oligonucleotides using standard synthetic methods234US 5,414,077 AGilead Sciences, Inc. · 1995
- Aminoalcohol lipidoids and uses thereof207US 8,450,298 B2Massachusetts Institute of Technology · 2013
- Electrochemical assay method with novel p-phenylenediamine compound196US 5,609,749 AMochida Pharmaceutical Co., Ltd. · 1997
- Retroviral protease inhibiting compounds159US 5,142,056 AAbbott Laboratories · 1992
- Method for immobilizing oligonucleotides employing the cycloaddition bioconjugation method143US 7,427,678 B2Sigma-Aldrich Co. · 2008